These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 8218351

  • 1. Type II phospholipase A2 in human gestational tissues: extractable immuno- and enzymatic activity in fetal membranes.
    Aitken MA, Farrugia W, Wong MH, Scott KF, Brennecke SP, Rice GE.
    Biochim Biophys Acta; 1993 Nov 03; 1170(3):314-20. PubMed ID: 8218351
    [Abstract] [Full Text] [Related]

  • 2. Secretory type II PLA2 immunoreactivity and PLA2 enzymatic activity in human gestational tissues before, during and after spontaneous-onset labour at term.
    Munns MJ, Farrugia W, King RG, Rice GE.
    Placenta; 1999 Jan 03; 20(1):21-6. PubMed ID: 9950141
    [Abstract] [Full Text] [Related]

  • 3. Type II phospholipase A2 in human gestational tissues: subcellular distribution of placental immuno- and catalytic activity.
    Farrugia W, Aitken MA, van Dunné F, Wong MH, Brennecke SP, Scott KF, Rice GE.
    Biochim Biophys Acta; 1993 Feb 10; 1166(1):77-83. PubMed ID: 8431495
    [Abstract] [Full Text] [Related]

  • 4. Localization of type II phospholipase A2 messenger RNA and immunoactivity in human placenta and fetal membranes.
    Aitken MA, Thomas T, Brennecke SP, Scott KF, Rice GE.
    Placenta; 1996 Sep 10; 17(7):423-9. PubMed ID: 8899871
    [Abstract] [Full Text] [Related]

  • 5. Contribution of type II phospholipase A2 to in vitro phospholipase A2 enzymatic activity in human term placenta.
    Rice GE, Wong MH, Farrugia W, Scott KF.
    J Endocrinol; 1998 Apr 10; 157(1):25-31. PubMed ID: 9614354
    [Abstract] [Full Text] [Related]

  • 6. Differential expression of type II, IV and cytosolic PLA2 messenger RNA in human intrauterine tissues at term.
    Freed KA, Moses EK, Brennecke SP, Rice GE.
    Mol Hum Reprod; 1997 Jun 10; 3(6):493-9. PubMed ID: 9239738
    [Abstract] [Full Text] [Related]

  • 7. Bacterial endotoxin increases type II phospholipase A2 immunoreactive content and phospholipase A2 enzymatic activity in human choriodecidua.
    Nguyen HT, Rice GE, Farrugia W, Wong M, Brennecke SP.
    Biol Reprod; 1994 Mar 10; 50(3):526-34. PubMed ID: 8167224
    [Abstract] [Full Text] [Related]

  • 8. Type II phospholipase A2 in preterm human gestational tissues.
    Lappas M, Permezel M, Georgiou HM, Rice GE.
    Placenta; 2001 Jan 10; 22(1):64-9. PubMed ID: 11162354
    [Abstract] [Full Text] [Related]

  • 9. Release of Type II phospholipase A2 immunoreactivity and phospholipase A2 enzymatic activity from human placenta.
    Farrugia W, Rice GE, Wong MH, Scott KF, Brennecke SP.
    J Endocrinol; 1997 Apr 10; 153(1):151-7. PubMed ID: 9157179
    [Abstract] [Full Text] [Related]

  • 10. Distribution of the phospholipase A2 receptor messenger RNA in human gestational tissues.
    Moses EK, Freed KA, Brennecke SP, Rice GE.
    Placenta; 1998 Jan 10; 19(1):35-40. PubMed ID: 9481783
    [Abstract] [Full Text] [Related]

  • 11. Secretory type II phospholipase A2 and the generation of intrauterine signals.
    Rice GE.
    Reprod Fertil Dev; 1995 Jan 10; 7(6):1471-9. PubMed ID: 8743149
    [Abstract] [Full Text] [Related]

  • 12. Regulation of phospholipase isozymes by nuclear factor-kappaB in human gestational tissues in vitro.
    Lappas M, Permezel M, Georgiou HM, Rice GE.
    J Clin Endocrinol Metab; 2004 May 10; 89(5):2365-72. PubMed ID: 15126565
    [Abstract] [Full Text] [Related]

  • 13. Gestational tissue phospholipase A2 messenger RNA content and the onset of spontaneous labour in the human.
    Aitken MA, Rice GE, Brennecke SP.
    Reprod Fertil Dev; 1990 May 10; 2(5):575-80. PubMed ID: 2075252
    [Abstract] [Full Text] [Related]

  • 14. Contribution of type II PLA2 to prostaglandin formation: a study using a type II PLA2 specific inhibitor SB 203347.
    Munns MJ, King RG, Rice GE.
    Prostaglandins Other Lipid Mediat; 1999 Jul 10; 57(5-6):361-70. PubMed ID: 10480490
    [Abstract] [Full Text] [Related]

  • 15. 15-Deoxy-Delta(12,14)-prostaglandin J(2) and troglitazone regulation of the release of phospholipid metabolites, inflammatory cytokines and proteases from human gestational tissues.
    Lappas M, Permezel M, Rice GE.
    Placenta; 2006 Jul 10; 27(11-12):1060-72. PubMed ID: 16434095
    [Abstract] [Full Text] [Related]

  • 16. Membranes exert indirect negative control on phospholipase A2 in human placenta.
    Buhl WJ, Zipfel M, Garcia MT, Eisenlohr LM, Gehring U.
    Eicosanoids; 1991 Jul 10; 4(4):235-44. PubMed ID: 1790000
    [Abstract] [Full Text] [Related]

  • 17. Secretory phospholipases and membrane polishing.
    Rice GE.
    Placenta; 1998 Jan 10; 19(1):13-20. PubMed ID: 9481780
    [Abstract] [Full Text] [Related]

  • 18. Antisense oligonucleotide inhibition of type II phospholipase A2 expression, release and activity in vitro.
    Lappas M, Munns MJ, King RG, Rice GE.
    Placenta; 2001 May 10; 22(5):418-24. PubMed ID: 11373152
    [Abstract] [Full Text] [Related]

  • 19. Fatty acid and phospholipid selectivity of different phospholipase A2 enzymes studied by using a mammalian membrane as substrate.
    Diez E, Chilton FH, Stroup G, Mayer RJ, Winkler JD, Fonteh AN.
    Biochem J; 1994 Aug 01; 301 ( Pt 3)(Pt 3):721-6. PubMed ID: 8053897
    [Abstract] [Full Text] [Related]

  • 20. Effect of bacterial endotoxin on the in vitro release of Type II phospholipase-A2 and prostaglandin E2 from human placenta.
    Farrugia W, Nicholls L, Rice GE.
    J Endocrinol; 1999 Feb 01; 160(2):291-6. PubMed ID: 9924199
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.